Extracorporeal Membrane Oxygenation Support In COVID-19: An International Cohort Study of The Extracorporeal Life Support Organization Registry
In patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or discharge were less than 40%. These data from 213 hospitals worldwide provide a generalisable estimate of ECMO mortality in the setting of COVID-19.